Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Myelodysplastic Syndromes; Preleukemia | Phase 2 | ClinicalTrials |
| Myelodysplastic Syndromes; Preleukemia; Syndrome | Phase 1/Phase 2 | ClinicalTrials |
| Myelodysplastic Syndromes; Preleukemia; Syndrome | Phase 1/Phase 2 | ClinicalTrials |
| Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia | Phase 1 | ClinicalTrials |
Related Entries
CONTENTS